Distinct T‐cell receptor profiles associated with hepatitis B e antigen seroconversion during entecavir treatment-Reference-Cited by-同舟云学术

Distinct T‐cell receptor profiles associated with hepatitis B e antigen seroconversion during entecavir treatment

Published:2020-07-14 Issue:11 Volume:40 Page:2672-2684
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int.

Author:

Lian Yi‐Fan¹^ORCID,Xu Ying²,Gu Yu‐Rong³^ORCID,Bi Yan‐Hua¹,Liao Chun‐Hong¹,Zhao Miao‐Xian²,Liao Xia‐Lin¹,Wang Zhan‐Hui²,Wu Hong‐Kai⁴,Huang Yue‐Hua¹³^ORCID

Affiliation:

1. Guangdong Provincial Key Laboratory of Liver Disease Research The Third Affiliated Hospital of Sun Yat‐sen University Guangzhou China

2. State Key Laboratory of Organ Failure Research Guangdong Provincial Key Laboratory of Viral Hepatitis Research Department of Infectious Diseases and Hepatology Unit Nanfang HospitalSouthern Medical University Guangzhou China

3. Department of Infectious Diseases The Third Affiliated Hospital of Sun Yat‐sen University Guangzhou China

4. State Key Laboratory of Respiratory Disease National Clinical Research Center for Respiratory Disease The First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou Medical University Guangzhou China

Funder

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14566

Reference25 articles.

1. HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B

2. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

3. Adaptive immunity in HBV infection